Skip Navigation



Carcinogenesis Advance Access published online on May 27, 2004
Carcinogenesis, doi:10.1093/carcin/bgh195
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/10/1983    most recent
bgh195v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mustacich, D.
Right arrow Articles by Powis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mustacich, D.
Right arrow Articles by Powis, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received January 19, 2004
Revised May 10, 2004
Accepted May 16, 2004

CARCINOGENESIS

Increased skin carcinogenesis in a keratinocyte directed thioredoxin-1 transgenic mouse

Debbie Mustacich 1, Amary Wagner 1, Ryan Williams 1, Warner Bair 1, Loreta Barbacheck 1, Steven Stratton 1, Achyut K. Bhattacharyya 2, Garth Powis 1*

1 Arizona Cancer Center, University of Arizona, Tucson, Arizona, 85724, USA
2 Department of Pathology, University of Arizona, Tucson, Arizona, 85724, USA

* To whom correspondence should be addressed. E-mail: gpowis{at}azcc.arizona.edu.


  Abstract

Thioredoxin-1 is a low molecular weight redox protein that protects cells against oxidant damage. Thioredoxin-1 levels are increased in the epidermal layer of sun damaged human skin. Thioredoxin-1 levels are also increased in several human primary tumors where its expression is associated with increased tumor cell proliferation, decreased apoptosis and aggressive tumor growth . We have investigated whether increased thioredoxin-1 levels in skin can lead to increased tumor formation using transgenic mice with mouse thioredoxin-1 expressed in keratinocytes under the control of the keratinocyte-14 (K14) promoter. Thioredoxin-1 protein expression was increased 2 fold in the keratinocyte layer of the transgenic mice. The skin was macroscopically and histologically normal but in the two stage model of carcinogenesis using topical dimethylbenzanthracene (DMBA) as an initiator and 12-O-tetradecanoylphorbol-13- acetate (TPA) as a promoting agent, there was a 6 fold increase in the number of papillomas per mouse and a 3 fold increase in papilloma size in the K14 thioredoxin-1 transgenic mice compared to non-transgenic littermates. Thus, increased thioredoxin-1 in keratinocytes acts as an enhancer of carcinogenesis in the DMBA/TPA two stage model of skin carcinogenesis in mice.

Key Words: thioredoxin-1, skin, keratinocytes, carcinogenesis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Ramalingam, J. B. Duhadaway, E. Sutanto-Ward, Y. Wang, J. Dinchuk, M. Huang, P. S. Donover, J. Boulden, L. M. McNally, A. P. Soler, et al.
Bin3 Deletion Causes Cataracts and Increased Susceptibility to Lymphoma during Aging
Cancer Res., March 15, 2008; 68(6): 1683 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Ablamunits, Y. Cohen, I. B. Brazee, H. P. Gaetz, C. Vinson, and S. Klebanov
Susceptibility to Induced and Spontaneous Carcinogenesis Is Increased in Fatless A-ZIP/F-1 but not in Obese ob/ob Mice.
Cancer Res., September 1, 2006; 66(17): 8897 - 8902.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.